Filing metadata

Accession number
0001104659-25-061267
Form type
Form 4
Filer
ArriVent BioPharma, Inc.
CIK
CIK 1868279
Filed
Jun 20, 2025
Reporting period
Jun 18, 2025
Description
Insider transaction

Explore SEC Filings Hub